BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19372473)

  • 1. A novel neutrophil-specific PET imaging agent: cFLFLFK-PEG-64Cu.
    Locke LW; Chordia MD; Zhang Y; Kundu B; Kennedy D; Landseadel J; Xiao L; Fairchild KD; Berr SS; Linden J; Pan D
    J Nucl Med; 2009 May; 50(5):790-7. PubMed ID: 19372473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 111In-LLP2A-DOTA Polyethylene Glycol-Targeting {alpha}4{beta}1 Integrin: Comparative Pharmacokinetics for Imaging and Therapy of Lymphoid Malignancies.
    Denardo SJ; Liu R; Albrecht H; Natarajan A; Sutcliffe JL; Anderson C; Peng L; Ferdani R; Cherry SR; Lam KS
    J Nucl Med; 2009 Apr; 50(4):625-34. PubMed ID: 19289419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GRP receptor-targeted PET of a rat pancreas carcinoma xenograft in nude mice with a 68Ga-labeled bombesin(6-14) analog.
    Schuhmacher J; Zhang H; Doll J; Mäcke HR; Matys R; Hauser H; Henze M; Haberkorn U; Eisenhut M
    J Nucl Med; 2005 Apr; 46(4):691-9. PubMed ID: 15809493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of novel neutrophil-specific imaging agents for Positron Emission Tomography (PET) imaging.
    Zhang Y; Kundu B; Fairchild KD; Locke L; Berr SS; Linden J; Pan D
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6876-8. PubMed ID: 17959381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A gallium-labeled DOTA-alpha-melanocyte- stimulating hormone analog for PET imaging of melanoma metastases.
    Froidevaux S; Calame-Christe M; Schuhmacher J; Tanner H; Saffrich R; Henze M; Eberle AN
    J Nucl Med; 2004 Jan; 45(1):116-23. PubMed ID: 14734683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical evaluation of a
    Jadvar H; Chen K; Park R; Yap LP; Vorobyova I; Swenson S; Markland FS
    Amino Acids; 2019 Nov; 51(10-12):1569-1575. PubMed ID: 31621030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.
    Wu Y; Zhang X; Xiong Z; Cheng Z; Fisher DR; Liu S; Gambhir SS; Chen X
    J Nucl Med; 2005 Oct; 46(10):1707-18. PubMed ID: 16204722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy.
    Lewis MR; Wang M; Axworthy DB; Theodore LJ; Mallet RW; Fritzberg AR; Welch MJ; Anderson CJ
    J Nucl Med; 2003 Aug; 44(8):1284-92. PubMed ID: 12902420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new PET tracer specific for vascular endothelial growth factor receptor 2.
    Wang H; Cai W; Chen K; Li ZB; Kashefi A; He L; Chen X
    Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2001-10. PubMed ID: 17694307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reagents and methods for PET using bispecific antibody pretargeting and 68Ga-radiolabeled bivalent hapten-peptide-chelate conjugates.
    Griffiths GL; Chang CH; McBride WJ; Rossi EA; Sheerin A; Tejada GR; Karacay H; Sharkey RM; Horak ID; Hansen HJ; Goldenberg DM
    J Nucl Med; 2004 Jan; 45(1):30-9. PubMed ID: 14734668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative radioimmunoPET imaging of EphA2 in tumor-bearing mice.
    Cai W; Ebrahimnejad A; Chen K; Cao Q; Li ZB; Tice DA; Chen X
    Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2024-36. PubMed ID: 17673999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts.
    Chen X; Park R; Hou Y; Tohme M; Shahinian AH; Bading JR; Conti PS
    J Nucl Med; 2004 Aug; 45(8):1390-7. PubMed ID: 15299066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a novel GRPR antagonist for prostate cancer PET imaging: [
    Mansour N; Paquette M; Ait-Mohand S; Dumulon-Perreault V; Guérin B
    Nucl Med Biol; 2018 Jan; 56():31-38. PubMed ID: 29154145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting formyl peptide receptor 1 of activated macrophages to monitor inflammation of experimental osteoarthritis in rat.
    Yang X; Chordia MD; Du X; Graves JL; Zhang Y; Park YS; Guo Y; Pan D; Cui Q
    J Orthop Res; 2016 Sep; 34(9):1529-38. PubMed ID: 26717557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 64Cu-labeled alpha-melanocyte-stimulating hormone analog for microPET imaging of melanocortin 1 receptor expression.
    Cheng Z; Xiong Z; Subbarayan M; Chen X; Gambhir SS
    Bioconjug Chem; 2007; 18(3):765-72. PubMed ID: 17348700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel near-infrared fluorescence imaging probe for in vivo neutrophil tracking.
    Xiao L; Zhang Y; Berr SS; Chordia MD; Pramoonjago P; Pu L; Pan D
    Mol Imaging; 2012; 11(5):372-82. PubMed ID: 22954181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET imaging of chemokine receptors in vascular injury-accelerated atherosclerosis.
    Liu Y; Pierce R; Luehmann HP; Sharp TL; Welch MJ
    J Nucl Med; 2013 Jul; 54(7):1135-41. PubMed ID: 23658218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of two novel ⁶⁴Cu-labeled RGD peptide radiotracers for enhanced PET imaging of tumor integrin αvβ₃.
    Hernandez R; Czerwinski A; Chakravarty R; Graves SA; Yang Y; England CG; Nickles RJ; Valenzuela F; Cai W
    Eur J Nucl Med Mol Imaging; 2015 Nov; 42(12):1859-68. PubMed ID: 26016906
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.